FDA Approves Capecitabine, First Oral Chemotherapy for the Treatment of Metastatic Colorectal Cancer. The US Food and Drug Administration (FDA) has approved capecitabine (Xeloda), the first oral chemotherapy for the treatment of metastatic colorectal cancer (the second leading cause of cancer mortality among Americans).
Are you looking for or in search of FDA approved “capecitabine tablets in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Colorectal Cancer. Need Access of capecitabine tablets, get in touch with our healthcare professional.
The FDA has approved the first generic formulation of capecitabine (Xeloda), an oral chemotherapeutic that is currently approved to treat patients with metastatic colorectal cancer (mCRC) and metastatic breast cancer (MBC). XELODA (capecitabine) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for:
• Adjuv ant Colon Cancer
• Metastatic Colorectal Cancer
• Metastatic Breast Cancer